Mercer Capital Advisers, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mercer Capital Advisers, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2021$380,000
-14.2%
4,650
-4.1%
0.20%
-8.1%
Q2 2021$443,000
+6.5%
4,8500.0%0.22%
-0.9%
Q1 2021$416,000
-9.2%
4,8500.0%0.22%
-12.2%
Q4 2020$458,000
+8.5%
4,8500.0%0.25%
-1.9%
Q3 2020$422,000
-0.5%
4,8500.0%0.26%
-4.1%
Q2 2020$424,000
+18.1%
4,850
+11.5%
0.27%
+1.9%
Q1 2020$359,000
-23.5%
4,350
-12.1%
0.26%
-5.7%
Q4 2019$469,000
+9.1%
4,9500.0%0.28%
+2.6%
Q3 2019$430,000
-4.9%
4,9500.0%0.27%
-6.5%
Q2 2019$452,000
-5.0%
4,9500.0%0.29%
-8.2%
Q1 2019$476,000
+9.9%
4,950
-2.0%
0.32%
-0.6%
Q4 2018$433,000
-0.5%
5,0500.0%0.32%
+10.7%
Q3 2018$435,000
+14.2%
5,0500.0%0.29%
+5.5%
Q2 2018$381,000
-6.6%
5,0500.0%0.28%
-8.3%
Q1 2018$408,000
-3.8%
5,0500.0%0.30%
-2.3%
Q4 2017$424,000
-11.7%
5,050
-9.7%
0.31%
-13.8%
Q3 2017$480,000
+2.8%
5,5900.0%0.36%
+1.7%
Q2 2017$467,000
+12.5%
5,5900.0%0.35%
+10.1%
Q1 2017$415,000
+2.0%
5,5900.0%0.32%
-2.2%
Q4 2016$407,000
-15.4%
5,590
-8.2%
0.32%
-15.8%
Q3 2016$481,000
-4.2%
6,0900.0%0.39%
-6.1%
Q2 2016$502,000
+13.8%
6,0900.0%0.41%
+9.0%
Q1 2016$441,000
-13.0%
6,090
+3.4%
0.38%
-15.7%
Q4 2015$507,000
-6.3%
5,8900.0%0.45%
-11.0%
Q3 2015$541,000
-6.6%
5,8900.0%0.50%
-3.1%
Q2 2015$579,000
-0.3%
5,8900.0%0.52%
-0.8%
Q1 2015$581,000
+4.7%
5,890
-1.7%
0.52%
+6.5%
Q4 2014$555,0005,9900.49%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders